善脂瑩膜衣錠 20 毫克

Country: Taiwan

Language: Chinese

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Active ingredient:

ATORVASTATIN (CALCIUM)

Available from:

瑩碩生技醫藥股份有限公司 台北市中山區南京東路二段206號8樓之3 (80207616)

ATC code:

C10AA05

Pharmaceutical form:

膜衣錠

Composition:

ATORVASTATIN (CALCIUM) (2406003120) MG

Units in package:

鋁箔盒裝;;塑膠瓶裝

Class:

製　劑

Prescription type:

須由醫師處方使用

Manufactured by:

歐帕生技醫藥股份有限公司 新竹縣湖口鄉光復路1號 TW

Therapeutic area:

atorvastatin

Therapeutic indications:

高膽固醇血症, 高三酸甘油脂血症。對於臨床上沒有冠心病的第二型糖尿病患者，但是至少有任一其他冠心病危險因子，包括高血壓、視網膜病變、白蛋白尿、或吸煙，atorvastatin適用於：降低心肌梗塞的風險、降低中風的風險。降低冠心病高危險群的心血管事件發生率對於臨床上沒有冠心病的高血壓患者，但是至少有三個其他冠心病危險因子，包括第二型糖尿病、年紀大於等於55 歲、微白蛋白尿或蛋白尿、吸煙或第一等親在55歲(男性)或60歲(女性)前曾經發生冠心病事件，atorvastatin適用於：降低心肌梗塞的風險、降低中風的風險、降低血管再造術與心絞痛的風險。

Product summary:

有效日期: 2028/01/04; 英文品名: Anxolightor F.C. Tablets 20 mg

Authorization date:

2008-01-04

Patient Information leaflet

10048879
G-9704
20049226
G-9945
40049288
G-9986 10
ANXOLIPO F.C. TABLET 10 MG 20
ANXOLIGHTOR F.C. TABLETS 20 MG 40
ANXOLIPO F.C. TABLETS 40 MG
Atorvastatin calcium
10Calcium carbonate, croscarmellose sodium, hydroxypropyl cellulose,
lactose monohydrate, magnesium stearate, microcrystalline cellulose,
polyoxyl 40
hydrogenated castor oil.
Coating :
Lecithin, polyethylene glycol, polyvinyl alcohol-
part
. hydrolyzed, talc, titanium dioxide.
20
40
Calcium carbonate, croscarmellose sodium, hydroxypropyl
cellulose, lactose powder, magnesium stearate, microcrystalline
cellulose, polyoxyl
40 hydrogenated castor oil.
Coating :
Lecithin, polyethylene glycol, polyvinyl alcohol-
part
. hydrolyzed, talc, titanium dioxide.
1.
atorvastatin
5555
(
)
60
()
atorvastatin
Atorvastatin(
)
(Fredrickson IIa
IIb
)
(LDL-)
B (apolipoprotein B)
(HDL-)
(Fredrickson IV
)
(Fredrickson III)
atorvastatin
(10-17)
Atorvastatin
(10-17
)
LDL-B
a. LDL-
≧
190 mg/dL
b. LDL-
≧
160 mg/dL
•
•
(
1
(NCEP))
1 (NCEP)
(mg/dL)
(mg/dL)
(mg/dL)
CHD
a
CHD
(1020%)
100
100
130
(100-129
b
)
2
(1020%)
130
130
10
10%-20%130
1010%160
0-1
c
160
160
190
(160-189
)
a
CHD
b
100 mg/dL
nicotinic acid
fibrate
c
0-11010%0-1
10
200 mg/dL
()
30 mg/dL
atorvastatin(
)
400 mg/dL (4.5 mmol/L)
(0.20[])
400 mg/dL (4.5 mmol/L)
Atorvastatin(Fredrickson IV
)
(mg/dL)
(mg/dL)
170
110
170-199
110-129
200
130
2.
atorvastatin
atorvastatin
atorvastatin 10-80 mg
LDL-(
)
atorvastatin/
2-4
a t o r v a s t a t i n
atorvastatin1080
(
)
atorvastatin 10 mg
atorvastatin 80 mgLDL
15%(18-45%)
(10-17
)
10 mg/
20 mg/(20 mg)
(
(NCEP)
)4
[(4)(5.2)]
atorvastatin
LDL-
Atorvastatin
[(11.3)]
3.
10
"AX022"
"10"
20
"AX063"
"20"
40
"AX023"
"40"
4.
•
•
• [(8.1)]
• [(8.2)]
5.
5.1
Atorvastatin
statinatorvastatin
(creatine phosphokinase
CPK)
10atorvastatin
cyclosporine
P450 3A4 (CYP3A4)(
clarithromycin
itraconazole
HIV
HCV
)/
statin(IMNM, immunemediated
necrotizing myopathy)
statin
/
CPK
atorvastatin
CPKatorvastatin
2
atorvastatin
Atorvastatin
[
(7)]
(CPK)
2
[
(2)
(7)
(11.3)]
2. /
C y c l o s p o r i